Hangzhou Alltest Biotech Co., Ltd. (688606.SS)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.19B
EV5.19B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
TTM
Revenue
18.9
26.8
35.2
165.4
272.9
493.6
222.2
Revenue % Chg.
—
42.0%
31.0%
370.5%
65.0%
80.9%
-58.6%
Cost of Revenue
7.0
10.0
13.3
29.4
122.3
197.8
115.8
Gross Profit
11.9
16.9
21.9
136.0
150.5
295.8
106.5
Gross Profit Margin
63.2%
62.9%
62.3%
82.3%
55.2%
59.9%
47.9%
R&D Expenses
3.8
4.5
5.2
8.0
13.9
30.2
28.6
Selling, General, & Admin Expenses
1.8
1.8
3.8
5.3
8.8
24.2
20.1
Other Expenses
0.5
1.1
0.6
2.4
1.1
3.7
4.2
Operating Income
5.5
9.1
12.8
115.5
130.6
203.0
24.3
Operating Income Margin
29.1%
34.0%
36.5%
69.8%
47.9%
41.1%
10.9%
Total Other Income/Expenses Net
0.0
0.0
-0.0
-0.2
-0.2
-1.8
3.5
Income Before Tax
5.5
9.1
12.8
115.3
130.4
201.2
27.8
Income Before Tax Margin
29.2%
34.0%
36.4%
69.7%
47.8%
40.8%
12.5%
Income Tax Expense
0.5
0.9
1.4
16.4
18.9
28.6
2.1
Net Income
5.0
8.2
11.4
98.9
111.5
172.5
25.7
Net Income Margin
26.3%
30.6%
32.5%
59.8%
40.9%
35.0%
11.5%
Weighted Avg. Shares Out
38.8
39.5
40.4
40.4
50.5
53.9
—
EPS
0.1
0.2
0.3
2.4
2.2
3.2
—
EPS % Chg.
—
62.5%
35.7%
767.0%
-9.9%
45.0%
—
Weighted Avg. Shares Out Dil
38.8
39.5
40.4
—
—
53.9
—
EPS Diluted
0.1
0.2
0.3
2.4
2.2
3.2
—
Interest Income
0.0
0.0
0.0
0.1
5.5
6.2
5.6
Interest Expense
0.2
-0.3
-0.2
2.7
0.1
0.3
0.3
EBIT
5.3
9.5
13.0
112.7
135.9
207.1
33.1
EBIT Margin
28.0%
35.3%
37.1%
68.2%
49.8%
42.0%
14.9%
Depreciation & Amortization
0.2
0.3
-0.3
8.3
1.9
51.9
40.1
EBITDA
5.5
9.8
12.7
121.0
137.7
259.0
73.2
EBITDA Margin
29.1%
36.6%
36.2%
73.2%
50.5%
52.5%
32.9%